AUG 09, 2018 7:00 AM PDT

3D Cell Cultures and Tissue Clearing: A High Content Confocal Platform for the Complete 3D Characterization of Advanced Cell Models

Sponsored by: Thermo Fisher Scientific
Speaker
  • Chief Executive Officer - Visikol Inc.
    Biography
      Michael Johnson, PhD is a 2017 and 2019 Forbes 30 Under 30 honoree and the CEO and Co-Founder of Visikol Inc., which is a bio-imaging company that spun out of Rutgers University in 2016 and that Michael founded along with his fellow PhD candidate Thomas Villani and colleague Nick Crider. Michael has a diverse background with experiences in both the technical and business considerations of running a biotech business. Following his undergraduate degree in biology at Muhlenberg College, Michael spent three years in various roles at Johnson & Johnson while concurrently pursuing a PhD in applied microbiology at Rutgers University. Michael's research background has focused on a wide-range of projects from remote sensing research with NASA to building light sheet microscopes and producing biofuels. Prior to launching Visikol, Michael worked on several other biotech-based entrepreneurial pursuits and is very passionate about translating cutting edge research into life-changing commercial technologies.

    Abstract

    DATE: August 9, 2018
    TIME: 7:00AM PDT

    With the advent of cost-effective culturing approaches, 3D cell culture models (3D-CCMs) have been rapidly adopted for drug discovery since they provide a more physiologically relevant micro-environment; showing improved predictive utility for assessing drug efficacy and/or toxicity when compared to traditional 2D monolayer models. High-content analysis/screening (HCA/HCS) also plays a major role in drug screening, but one of the unique challenges of evaluating 3D-CCMs (i.e. spheroids, organoids, micro-tissues, organs-on-a-chip) is their opacity and thickness that limit optical imaging to only the outermost layers (~20=30 microns). Since the outermost cells are exposed to different physiological test conditions (oxygen, nutrients, media exchange, drug dosing), current image-based approaches induce a bias in the results since the outer layer of cells are found in a significantly different micro-environment than the interior. This shortcoming is particularly problematic when ascertaining the relative effectiveness of current therapeutic agents (e.g. immunoglobulin-based therapeutics, anti-proliferatives) since their effects are likely to be localized or concentrated to the surface while their efficacy within the interior are obfuscated and not fully resolved. Visikol™ has shown that through the addition of high content confocal microscopy with the Thermo Scientific™ CellInsight™ CX7 LZR High-Content Analysis Platform and the Invitrogen™ CytoVista™ 3D Cell Culture Clearing Reagent that the entire population of cells within 3D-CCMs can be characterized.

    Learning Objectives:

    • Benefits of imaging 3D Cell Cultures 
    • Practical considerations for buying a High-Content Analysis Platform

    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    APR 01, 2021 8:00 AM PDT
    C.E. CREDITS
    APR 01, 2021 8:00 AM PDT
    Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
    AUG 09, 2018 7:00 AM PDT

    3D Cell Cultures and Tissue Clearing: A High Content Confocal Platform for the Complete 3D Characterization of Advanced Cell Models

    Sponsored by: Thermo Fisher Scientific

    Specialty

    Cell Biology

    Cell Culture

    Cancer Research

    Molecular Biology

    Biotechnology

    Immunology

    Cancer Therapeutics

    Cell Signaling / Transduction

    Biomarkers

    Drug Discovery

    Biochemistry

    Gene Expression

    Assay Development

    Genetics

    Cancer Diagnostics

    Geography

    North America53%

    Europe22%

    Asia12%

    South America4%

    Oceania3%

    Africa2%

    Registration Source

    Website Visitors62%

    WAVE Newsletter Promotion20%

    Email Promotions14%

    Social Media Promotions2%

    Website Banners1%

    Trending Newsletter Promotion1%

    Other1%

    Job Title

    Research Scientist18%

    Student15%

    Executive11%

    Scientist11%

    Post Doc8%

    Medical Laboratory Technician8%

    Educator/Faculty8%

    Facility/Department Manager7%

    Medical Doctor/Specialist3%

    Clinical Laboratory Scientist3%

    Marketing/Sales2%

    Lab Management2%

    Biologist1%

    Engineer1%

    Organization

    Academic Institution22%

    Biotech Company14%

    Research Institute13%

    Hospital6%

    Life Science Company6%

    Medical School5%

    Government4%

    Clinical Laboratory4%

    Pharmaceutical Company4%

    Medical Center3%

    Industrial Company2%

    Non-Profit Organization2%

    Contract Research Organization (Cro)2%

    Consultant1%

    Other5%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more